|
|
||||||||
Correspondence to:
Peter Vreken, at the University of Amsterdam Academic Medical Center, Laboratory of Genetic Metabolic Diseases, F0-224, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands., p.vreken{at}amc.uva.nl (E-mail)
We identified a new peroxisomal disorder caused by a deficiency of the enzyme
We found that racemase-deficient patients accumulate exclusively the (R)-isomer of free and taurine-conjugated DHCA and THCA, whereas in plasma of patients with Zellweger syndrome and patients with cholestatic liver disease both isomers were present. On the basis of these results we describe an easy and reliable method for the diagnosis of
Supplementary key words:
bile acid intermediates, peroxisomal ß-oxidation, stereochemistry
Copyright © 2001 by Lipid Research, Inc.
Original Article
Plasma analysis of di- and trihydroxycholestanoic acid diastereoisomers in peroxisomal
Sacha Ferdinandussea,
Henk Overmarsa,
Simone Denisa,
Hans R. Waterhamb,
Ronald J. A. Wandersa,b, and
Peter Vrekena
-methylacyl-CoA racemase deficiency
a Department of Clinical Chemistry, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
b Department of Pediatrics, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
-methylacyl-coenzyme A (CoA) racemase. Patients with this disorder show elevated plasma levels of pristanic acid and the bile acid intermediates di- and trihydroxycholestanoic acid (DHCA and THCA), which are all substrates for the peroxisomal ß-oxidation system.
-Methylacyl-CoA racemase plays an important role in the ß-oxidation of branched-chain fatty acids and fatty acid derivatives because it catalyzes the conversion of several (2R)-methyl-branched-chain fatty acyl-CoAs to their (2S)-isomers. Only stereoisomers with the 2-methyl group in the (S)-configuration can be degraded via ß-oxidation. In this study we used liquid chromatography/tandem mass spectrometry (LC-MS/MS) to analyze the bile acid intermediates that accumulate in plasma from patients with a deficiency of
-methylacyl-CoA racemase and, for comparison, in plasma from patients with Zellweger syndrome and patients with cholestatic liver disease.
-methylacyl-CoA racemase-deficient patients by plasma analysis. Our results also show that
-methylacyl-CoA racemase plays a unique role in bile acid formation. Ferdinandusse, S., H. Overmars, S. Denis, H. R. Waterham, R. J. A. Wanders, and P. Vreken. Plasma analysis of di- and trihydroxycholestanoic acid diastereoisomers in peroxisomal
-methylacyl-CoA racemase deficiency. J. Lipid Res. 2001. 42: 137;141. ![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Kuefer, S. Varambally, M. Zhou, P. C. Lucas, M. Loeffler, H. Wolter, T. Mattfeldt, R. E. Hautmann, J. E. Gschwend, T. R. Barrette, et al. {alpha}-Methylacyl-CoA Racemase: Expression Levels of this Novel Cancer Biomarker Depend on Tumor Differentiation Am. J. Pathol., September 1, 2002; 161(3): 841 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Rubin, M. Zhou, S. M. Dhanasekaran, S. Varambally, T. R. Barrette, M. G. Sanda, K. J. Pienta, D. Ghosh, and A. M. Chinnaiyan {alpha}-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer JAMA, April 3, 2002; 287(13): 1662 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ferdinandusse, H. Rusch, A. E. M. van Lint, G. Dacremont, R. J. A. Wanders, and P. Vreken Stereochemistry of the peroxisomal branched-chain fatty acid {alpha}- and {beta}-oxidation systems in patients suffering from different peroxisomal disorders J. Lipid Res., March 1, 2002; 43(3): 438 - 444. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |